Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp's Monogram Acquisition Clears Antitrust Review

NEW YORK (GenomeWeb News) – Laboratory Corporation of America's $107 million acquisition of Monogram Biosciences has cleared US antitrust review, the clinical lab giant said today.

Under the deal announced last month, LabCorp will acquire all of the outstanding shares of Monogram in a cash offer of $4.55 per share for a total equity value of $106.7 million. The acquisition price represented a significant premium over Monogram's closing price of $1.68 on the Nasdaq the day before the acquisition was announced.

The tender offer is scheduled to expire at the end of the day on July 29, unless it is extended. The firms previously said that they hope to close the acquisition during the third quarter.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.